Showing 2,371 news articles about HIV treatment

Filters Content type: Editors' picks Topic: HIV treatment

Treatment is recommended for all people living with HIV. It involves taking a combination of antiretroviral drugs. This stops the virus from replicating and allows the immune system to strengthen and fight infections.

Experiences of stigma

Linking HIV stigma, denial and poor health 

Editor's pick
AVERT
8 November 2018
Injectable & long-acting HIV treatment

ViiV’s Long-Acting Injectable HIV Regimen Boasts Good 3-Year Results

Editor's pick
Poz
5 November 2018
Cardiovascular disease

Cardiovascular Risk Unclear for HIV Patients on Dolutegravir

Editor's pick
Medscape (requires free registration)
1 November 2018
Starting treatment

Janssen Presents Positive Long-Term Efficacy and Safety of SYMTUZA in Treatment-Naïve Adults with HIV-1

Editor's pick
Janssen press release
1 November 2018
Starting treatment

Gilead Announces 96-Week Results From Phase 3 Study of Biktarvy® (Bictegravir, Emtricitabine, Tenofovir Alafenamide) for the Treatment of HIV-1 in Adults New to HIV Therapy

Editor's pick
Gilead press release
1 November 2018
Bad science & bogus treatments

'No cure' for HIV in Zimbabwe says UN, following claims from local preacher

Editor's pick
UN News
1 November 2018
New & experimental HIV treatments

Long-lasting HIV injection is a step closer after second GSK study

Editor's pick
Reuters
31 October 2018
Adherence

How substance use affects adherence to PrEP among gay and bisexual men

Editor's pick
Medical Xpress
24 October 2018
Child developmental issues

Dolutegravir Use During Pregnancy: What Are the Risks?

Editor's pick
Infectious Disease Advisor
22 October 2018
New & experimental HIV treatments

ViiV Seeks FDA Approval for Two-Drug HIV Treatment

Editor's pick
Poz
22 October 2018
The search for a cure

Gilead and Aelix join forces to pursue HIV 'cure'

Editor's pick
PMLiVE
18 October 2018
Starting treatment

Rapid Initiation of HIV Care: Assessing Safety and Efficacy

Editor's pick
Infectious Disease Advisor
16 October 2018
New & experimental HIV treatments

Long-acting injectable implant shows promise for HIV treatment and prevention

Editor's pick
University of North Carolina
9 October 2018
Changing treatment

Merck’s HIV Therapy DELSTRIGO™ (doravirine / lamivudine / tenofovir disoproxil fumarate) Meets Primary Efficacy Endpoint in Phase 3 DRIVE-SHIFT Study Evaluating Switch to DELSTRIGO from Other Antiretroviral Treatment Regimens

Editor's pick
Merck press release
5 October 2018
Changing treatment

Janssen Reports Switching to SYMTUZA™ Results in Maintained High Virologic Suppression and No Resistance Development up to 96-Weeks in Virologically Suppressed Adults with HIV-1

Editor's pick
Janssen press release
5 October 2018
Child developmental issues

Efavirenz in HIV-positive pregnant women, risk of neurological condition in children

Editor's pick
IDSA press release
5 October 2018
The search for a cure

Vedolizumab could be used to target latent HIV harboring in gut

Editor's pick
Healio
4 October 2018
New & experimental HIV treatments

Gilead Announces 96-Week Results From Phase 3 Study of Biktarvy® (Bictegravir, Emtricitabine, Tenofovir Alafenamide) for the Treatment of HIV-1 in Adults New to HIV Therapy

Editor's pick
Gilead press release
3 October 2018
New & experimental HIV treatments

HIV drug Symtuza® receives NHS England funding

Editor's pick
Pharmafield
28 September 2018
The search for a cure

Powerful antibodies suppress HIV for months, could simplify treatment

Editor's pick
Science
28 September 2018
How HIV works

PET Scans May Predict Who Gets Inflammatory Reaction to HIV Treatment Start

Editor's pick
Poz
26 September 2018
The search for a cure

Proof-of-concept HIV immunotherapy study passes Phase 1 safety trial

Editor's pick
Science Daily
24 September 2018
New & experimental HIV treatments

European advisory group backs Merck's HIV meds Delstrigo and Pifeltro

Editor's pick
Seeking Alpha
24 September 2018
New & experimental HIV treatments

NIH launches study to test combination antibody treatment for HIV infection

Editor's pick
National Institutes of Health
21 September 2018